Share-Based Compensation (Details) - USD ($) $ / shares in Units, $ in Thousands | 1 Months Ended | 12 Months Ended | |
Aug. 31, 2014 | Aug. 31, 2013 | Jun. 26, 2015 | Jun. 27, 2014 | Jun. 28, 2013 | Oct. 31, 2014 |
Share-Based Benefit Plans: | | | | | | |
Stock awards, term from grant date to expiration | | | 10 years | | | |
Award vesting period (generally) | | | 4 years | | | |
Weighted average fair value assumptions: | | | | | | |
Share-based compensation | | | $ 14,549 | $ 11,979 | $ 10,100 | |
Restricted stock activity, weighted average grant date fair value: | | | | | | |
Amounts withheld for taxes | | | $ 2,482 | $ 2,685 | $ 2,080 | |
Stock options | | | | | | |
Options outstanding, shares: | | | | | | |
Options outstanding, beginning of period (in shares) | | | 1,608,436 | 2,281,401 | | |
Options granted (in shares) | | | 0 | 0 | | |
Options exercised (in shares) | | | (69,471) | (492,825) | | |
Options cancelled (in shares) | | | (152,395) | (180,140) | | |
Options outstanding, end of period (in shares) | | | 1,386,570 | 1,608,436 | 2,281,401 | |
Vested and expected to vest (in shares) | | | 1,380,502 | | | |
Exercisable (in shares) | | | 1,279,754 | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Options outstanding, beginning balance, weighted average exercise price (USD per share) | | | $ 10.53 | $ 10.56 | | |
Options granted, weighted average exercise price (USD per share) | | | 0 | 0 | | |
Options exercised, weighted average exercise price (USD per shares) | | | 5.80 | 7.83 | | |
Options cancelled, weighted average exercise price (USD per share) | | | 13.75 | 18.32 | | |
Options outstanding, ending balance, weighted average exercise price (USD per share) | | | 10.41 | $ 10.53 | $ 10.56 | |
Vested and expected to vest, weighted average exercise price (USD per share) | | | 10.42 | | | |
Exercisable, weighted average exercise price (USD per share) | | | $ 10.56 | | | |
Options outstanding, weighted average remaining contractual term | | | 4 years 9 months 11 days | | | |
Vested and expected to vest, weighted average remaining contractual term | | | 4 years 9 months 11 days | | | |
Exercisable, weighted average remaining contractual term | | | 4 years 7 months 13 days | | | |
Options outstanding, aggregate intrinsic value | | | $ 354 | | | |
Vested and expected to vest, aggregate intrinsic value | | | 351 | | | |
Exercisable, aggregate intrinsic value | | | 325 | | | |
Total intrinsic value of options exercised in period | | | 200 | $ 3,900 | $ 4,400 | |
Total fair value of shares vested during period | | | 1,500 | $ 2,500 | $ 4,100 | |
Total unrecognized compensation cost related to non-vested awards, options | | | $ 0 | | | |
Total compensation cost related to non-vested awards, period for recognition | | | 4 months 30 days | | | |
Stock options | $5.07 - $5.07 | | | | | | |
Options outstanding, shares: | | | | | | |
Options outstanding, end of period (in shares) | | | 18,568 | | | |
Exercisable (in shares) | | | 18,568 | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Options outstanding, ending balance, weighted average exercise price (USD per share) | | | $ 5.07 | | | |
Exercisable, weighted average exercise price (USD per share) | | | $ 5.07 | | | |
Options outstanding, weighted average remaining contractual term | | | 3 years 11 months 1 day | | | |
Exercise price range, lower range limit (USD per share) | | | $ 5.07 | | | |
Exercise price range, upper range limit (USD per share) | | | $ 5.07 | | | |
Stock options | $5.34 - $5.34 | | | | | | |
Options outstanding, shares: | | | | | | |
Options outstanding, end of period (in shares) | | | 180,594 | | | |
Exercisable (in shares) | | | 180,594 | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Options outstanding, ending balance, weighted average exercise price (USD per share) | | | $ 5.34 | | | |
Exercisable, weighted average exercise price (USD per share) | | | $ 5.34 | | | |
Options outstanding, weighted average remaining contractual term | | | 4 years 25 days | | | |
Exercise price range, lower range limit (USD per share) | | | $ 5.34 | | | |
Exercise price range, upper range limit (USD per share) | | | $ 5.34 | | | |
Stock options | $5.60 - $7.46 | | | | | | |
Options outstanding, shares: | | | | | | |
Options outstanding, end of period (in shares) | | | 145,972 | | | |
Exercisable (in shares) | | | 105,825 | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Options outstanding, ending balance, weighted average exercise price (USD per share) | | | $ 5.97 | | | |
Exercisable, weighted average exercise price (USD per share) | | | $ 6 | | | |
Options outstanding, weighted average remaining contractual term | | | 6 years 10 months 6 days | | | |
Exercise price range, lower range limit (USD per share) | | | $ 5.60 | | | |
Exercise price range, upper range limit (USD per share) | | | $ 7.46 | | | |
Stock options | $7.73 - $7.99 | | | | | | |
Options outstanding, shares: | | | | | | |
Options outstanding, end of period (in shares) | | | 145,720 | | | |
Exercisable (in shares) | | | 145,720 | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Options outstanding, ending balance, weighted average exercise price (USD per share) | | | $ 7.84 | | | |
Exercisable, weighted average exercise price (USD per share) | | | $ 7.84 | | | |
Options outstanding, weighted average remaining contractual term | | | 3 years 11 months 23 days | | | |
Exercise price range, lower range limit (USD per share) | | | $ 7.73 | | | |
Exercise price range, upper range limit (USD per share) | | | $ 7.99 | | | |
Stock options | $8.98 - $9.68 | | | | | | |
Options outstanding, shares: | | | | | | |
Options outstanding, end of period (in shares) | | | 107,500 | | | |
Exercisable (in shares) | | | 107,500 | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Options outstanding, ending balance, weighted average exercise price (USD per share) | | | $ 9.05 | | | |
Exercisable, weighted average exercise price (USD per share) | | | $ 9.05 | | | |
Options outstanding, weighted average remaining contractual term | | | 4 years 4 months 20 days | | | |
Exercise price range, lower range limit (USD per share) | | | $ 8.98 | | | |
Exercise price range, upper range limit (USD per share) | | | $ 9.68 | | | |
Stock options | $9.78 - $9.78 | | | | | | |
Options outstanding, shares: | | | | | | |
Options outstanding, end of period (in shares) | | | 212,396 | | | |
Exercisable (in shares) | | | 151,458 | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Options outstanding, ending balance, weighted average exercise price (USD per share) | | | $ 9.78 | | | |
Exercisable, weighted average exercise price (USD per share) | | | $ 9.78 | | | |
Options outstanding, weighted average remaining contractual term | | | 6 years 8 months 5 days | | | |
Exercise price range, lower range limit (USD per share) | | | $ 9.78 | | | |
Exercise price range, upper range limit (USD per share) | | | $ 9.78 | | | |
Stock options | $9.82 - $11.40 | | | | | | |
Options outstanding, shares: | | | | | | |
Options outstanding, end of period (in shares) | | | 139,783 | | | |
Exercisable (in shares) | | | 139,783 | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Options outstanding, ending balance, weighted average exercise price (USD per share) | | | $ 10.62 | | | |
Exercisable, weighted average exercise price (USD per share) | | | $ 10.62 | | | |
Options outstanding, weighted average remaining contractual term | | | 5 years 18 days | | | |
Exercise price range, lower range limit (USD per share) | | | $ 9.82 | | | |
Exercise price range, upper range limit (USD per share) | | | $ 11.40 | | | |
Stock options | $11.61 - $13.47 | | | | | | |
Options outstanding, shares: | | | | | | |
Options outstanding, end of period (in shares) | | | 148,454 | | | |
Exercisable (in shares) | | | 148,454 | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Options outstanding, ending balance, weighted average exercise price (USD per share) | | | $ 11.96 | | | |
Exercisable, weighted average exercise price (USD per share) | | | $ 11.96 | | | |
Options outstanding, weighted average remaining contractual term | | | 4 years 9 months 25 days | | | |
Exercise price range, lower range limit (USD per share) | | | $ 11.61 | | | |
Exercise price range, upper range limit (USD per share) | | | $ 13.47 | | | |
Stock options | $14.01 - $14.69 | | | | | | |
Options outstanding, shares: | | | | | | |
Options outstanding, end of period (in shares) | | | 161,083 | | | |
Exercisable (in shares) | | | 155,352 | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Options outstanding, ending balance, weighted average exercise price (USD per share) | | | $ 14.60 | | | |
Exercisable, weighted average exercise price (USD per share) | | | $ 14.60 | | | |
Options outstanding, weighted average remaining contractual term | | | 4 years 11 months 19 days | | | |
Exercise price range, lower range limit (USD per share) | | | $ 14.01 | | | |
Exercise price range, upper range limit (USD per share) | | | $ 14.69 | | | |
Stock options | $16.85 - $37.91 | | | | | | |
Options outstanding, shares: | | | | | | |
Options outstanding, end of period (in shares) | | | 126,500 | | | |
Exercisable (in shares) | | | 126,500 | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Options outstanding, ending balance, weighted average exercise price (USD per share) | | | $ 21.33 | | | |
Exercisable, weighted average exercise price (USD per share) | | | $ 21.33 | | | |
Options outstanding, weighted average remaining contractual term | | | 1 year 25 days | | | |
Exercise price range, lower range limit (USD per share) | | | $ 16.85 | | | |
Exercise price range, upper range limit (USD per share) | | | $ 37.91 | | | |
Stock options | $5.07 - $37.91 | | | | | | |
Options outstanding, shares: | | | | | | |
Options outstanding, end of period (in shares) | | | 1,386,570 | | | |
Exercisable (in shares) | | | 1,279,754 | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Options outstanding, ending balance, weighted average exercise price (USD per share) | | | $ 10.41 | | | |
Exercisable, weighted average exercise price (USD per share) | | | $ 10.56 | | | |
Options outstanding, weighted average remaining contractual term | | | 4 years 9 months 11 days | | | |
Exercise price range, lower range limit (USD per share) | | | $ 5.07 | | | |
Exercise price range, upper range limit (USD per share) | | | $ 37.91 | | | |
Restricted stock units (RSUs) | | | | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Options outstanding, weighted average remaining contractual term | | | 1 year 2 months 19 days | | | |
Vested and expected to vest, weighted average remaining contractual term | | | 1 year 11 days | | | |
Total compensation cost related to non-vested awards, period for recognition | | | 1 year 3 months 8 days | | | |
Restricted stock activity, number of shares: | | | | | | |
Equity instruments other than options, outstanding, beginning of period (in shares) | | | 1,696,823 | 1,337,767 | | |
Released (in shares) | | | (804,420) | (558,481) | | |
Forfeited (in shares) | | | (459,840) | (320,430) | | |
Awarded (in shares) | | | 1,273,510 | 1,237,967 | | |
Equity instruments other than options, outstanding, end of period (in shares) | | | 1,706,073 | 1,696,823 | 1,337,767 | |
Equity instruments other than options, vested and expected to vest (in shares) | | | 1,368,290 | | | |
Restricted stock activity, weighted average grant date fair value: | | | | | | |
Equity intstruments other than options, outstanding, weighted average grant date fair value, beginning of period (in shares) | | | $ 12.67 | $ 10.27 | | |
Released, weighted average grant date fair value (USD per share) | | | 8.90 | 12.17 | | |
Forfeited, weighted average grant date fair value (USD per share) | | | 12.82 | 11.98 | | |
Awarded, weighted average grant date fair value (USD per share) | | | 9.44 | 14.41 | | |
Equity intstruments other than options, outstanding, weighted average grant date fair value, end of period (in shares) | | | 10.81 | $ 12.67 | $ 10.27 | |
Equity instruments other than options, vested and expected to vest, weighted average grant date fair value (USD per share) | | | $ 10.66 | | | |
Equity instruments other than options, nonvested, intrinsic value | | | $ 11,243 | | | |
Equity instruments other than options, vested and expected to vest, outstanding, intrinsic value | | | 9,079 | | | |
Total unrecognized compensation cost related to non-vested awards, equity instruments other than options | | | $ 6,700 | | | |
Time-based RSUs | Executive Officer | | | | | | |
Share-Based Benefit Plans: | | | | | | |
Award vesting period (generally) | 4 years | 4 years | | | | |
RSUs and RSAs | | | | | | |
Restricted stock activity, weighted average grant date fair value: | | | | | | |
Shares withheld for taxes (in shares) | | | 278,733,000 | 214,304,000 | 159,829,000 | |
Amounts withheld for taxes | | | $ 2,482 | $ 2,671 | $ 2,080 | |
Cost of revenue | Continuing operations | | | | | | |
Weighted average fair value assumptions: | | | | | | |
Share-based compensation | | | 1,962 | 1,676 | 1,598 | |
Research and development | Continuing operations | | | | | | |
Weighted average fair value assumptions: | | | | | | |
Share-based compensation | | | 2,318 | 2,072 | 2,250 | |
Sales and marketing | Continuing operations | | | | | | |
Weighted average fair value assumptions: | | | | | | |
Share-based compensation | | | 2,771 | 2,598 | 1,629 | |
General and administrative | Continuing operations | | | | | | |
Weighted average fair value assumptions: | | | | | | |
Share-based compensation | | | $ 7,498 | $ 5,633 | $ 4,623 | |
Option Plan | | | | | | |
Weighted average fair value assumptions: | | | | | | |
Risk-free interest rate | | | | | 0.70% | |
Volatility | | | | | 66.10% | |
Weighted average expected life (in years) | | | | | 4 years 11 months 26 days | |
Expected dividend yield | | | | | 0.00% | |
Weighted average grant date fair value (USD per share) | | | | | $ 4.83 | |
Equity Incentive Plan - 2005 | | | | | | |
Share-Based Benefit Plans: | | | | | | |
Number of shares available for grant | | | 0 | | | |
Number of additional shares authorized | | | 0 | 798,805 | 886,075 | |
Non-Employee Directors' Stock Option Plan - 2005 | | | | | | |
Share-Based Benefit Plans: | | | | | | |
Number of shares available for grant | | | 0 | | | |
Number of additional shares authorized | | | 0 | 0 | 0 | |
Employee Stock Purchase Plan - 2005 | | | | | | |
Share-Based Benefit Plans: | | | | | | |
Number of shares available for grant | | | 2,135,225 | | | |
Number of additional shares authorized | | | 2,000,000 | 365,263 | 51,653 | |
Weighted average fair value assumptions: | | | | | | |
Risk-free interest rate | | | 0.20% | 0.20% | 0.20% | |
Volatility | | | 49.10% | 56.70% | 79.40% | |
Weighted average expected life (in years) | | | 1 year 3 months | 1 year 3 months | 1 year 3 months | |
Expected dividend yield | | | 0.00% | 0.00% | 0.00% | |
Weighted average grant date fair value (USD per share) | | | $ 3.23 | $ 5.59 | $ 4.84 | |
Employee Stock Purchase Plan: | | | | | | |
Shares issued (in shares) | | | 457,125,000 | 540,448,000 | 485,707,000 | |
Weighted-average purchase price per share (USD per share) | | | $ 7.58 | $ 7.92 | $ 7.09 | |
Employee Stock Purchase Plan - 2005 | Employee Stock | | | | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Total compensation cost related to non-vested awards, period for recognition | | | 1 year 7 months 6 days | | | |
Restricted stock activity, weighted average grant date fair value: | | | | | | |
Total unrecognized compensation cost related to non-vested awards, equity instruments other than options | | | $ 1,000 | | | |
New Recruit Equity Incentive Plan - 2006 | | | | | | |
Share-Based Benefit Plans: | | | | | | |
Number of shares available for grant | | | 293,339 | | | |
Percent of fair market value in which exercise price must exceed | | | 100.00% | | | |
Omnibus Incentive Plan - 2014 | | | | | | |
Share-Based Benefit Plans: | | | | | | |
Number of shares available for grant | | | 2,717,855 | | | |
Number of shares available for grant, transferred from the 2005 Plan to the 2014 Plan | | | 312,877 | | | |
Number of shares authorized | | | | | | 2,500,000 |